These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 2669367)
1. [Changes in the renin-angiotensin-aldosterone system in elderly patients with chronic ischemic heart disease. 4. The renin-angiotensin-aldosterone system in elderly patients with ischemic heart disease and cardiovascular insufficiency]. Korkusko OV; Kalinovskaja EG; Fedirko MI; Gidzinskaja IN Z Alternsforsch; 1989; 44(3):149-54. PubMed ID: 2669367 [TBL] [Abstract][Full Text] [Related]
2. [Changes in the renin-angiotensin-aldosterone system in elderly patients with chronic ischemic heart disease. 3. The renin-angiotensin-aldosterone system in elderly patients with ischemic heart disease without cardiovascular failure]. Korkusko V; Kalinovskaja EG; Fedirko MI; Gidzinskaja IN Z Alternsforsch; 1989; 44(3):141-8. PubMed ID: 2669366 [TBL] [Abstract][Full Text] [Related]
3. [Captopril in the treatment of refractory cardiac insufficiency]. Gorb IuG Ter Arkh; 1985; 57(12):63-7. PubMed ID: 3911466 [TBL] [Abstract][Full Text] [Related]
4. [The renin-angiotensin-aldosterone system and antidiuretic hormone in chronic circulatory failure in elderly subjects]. Khaĭdarova GKh Ter Arkh; 1992; 64(3):109-11. PubMed ID: 1440254 [TBL] [Abstract][Full Text] [Related]
5. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)]. Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624 [No Abstract] [Full Text] [Related]
6. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise. Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808 [TBL] [Abstract][Full Text] [Related]
7. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure. Rademaker MT; Charles CJ; Nicholls MG; Richards AM Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934 [TBL] [Abstract][Full Text] [Related]
8. [Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis]. Radzevich AE; Ditiatkov AE; Tikhonov VA Probl Tuberk; 2001; (5):16-9. PubMed ID: 11588951 [TBL] [Abstract][Full Text] [Related]
9. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme]. Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239 [TBL] [Abstract][Full Text] [Related]
10. Role of angiotensin-converting enzyme inhibitors in congestive heart failure. Galvao M Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159 [TBL] [Abstract][Full Text] [Related]
11. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease. Dzau VJ; Swartz SL Am J Cardiol; 1987 Nov; 60(13):1101-5. PubMed ID: 3314460 [TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic changes during captopril inhibition of the renin-angiotensin-aldosterone system in patients with circulatory failure following heart valve prosthesis]. Anokhin VN; Vladimirov PV; Marshutin NA; Migalina LA; Zenkov VE Revmatologiia (Mosk); 1988; (2):43-8. PubMed ID: 3051276 [No Abstract] [Full Text] [Related]
13. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril]. Jiang M Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233 [TBL] [Abstract][Full Text] [Related]
14. Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock. van Diepen S; Reynolds HR; Stebbins A; Lopes RD; Džavík V; Ruzyllo W; Geppert A; Widimsky P; Ohman EM; Parrillo JE; Dauerman HL; Baran DA; Hochman JS; Alexander JH Crit Care Med; 2014 Feb; 42(2):281-8. PubMed ID: 23982033 [TBL] [Abstract][Full Text] [Related]
15. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046 [TBL] [Abstract][Full Text] [Related]
16. Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment. Riegger GA; Haeske W; Kraus C; Kromer EP; Kochsiek K Am J Cardiol; 1987 Apr; 59(8):906-10. PubMed ID: 3548307 [TBL] [Abstract][Full Text] [Related]
17. [Effect of hyperbaric oxygenation on the status of the renin-angiotensin-aldosterone system in chronic circulatory insufficiency in elderly patients with ischemic heart disease]. Khaĭdarova GKh; Borukhova ES; Asinova MI Anesteziol Reanimatol; 1989; (3):33-5. PubMed ID: 2802239 [TBL] [Abstract][Full Text] [Related]
18. [The effect of hemodynamic changes in 24-hour milrinone infusion on sympathetic activity and the renin-angiotensin-aldosterone system in patients with severe heart failure]. Mager G; Steffen HM; Klocke RK; Wambach G; Kux A; Degenhardt S; Höpp HW; Hilger HH Z Kardiol; 1991 Apr; 80(4):272-8. PubMed ID: 1862668 [TBL] [Abstract][Full Text] [Related]
19. Plasma vasopressin as influenced by acute and chronic blockade of the renin-angiotensin system. Stanek B; Bruckner U; Silberbauer K J Hypertens Suppl; 1985 Nov; 3(2):S129-31. PubMed ID: 3003301 [TBL] [Abstract][Full Text] [Related]
20. The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences? Klotz S; Burkhoff D; Garrelds IM; Boomsma F; Danser AH Eur Heart J; 2009 Apr; 30(7):805-12. PubMed ID: 19223317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]